Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessResearch

Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009

Sébastien Héritier1 email, Martine Le Merrer2 email, Francis Jaubert3 email, Michèle Bigorre4 email, Marion Gillibert-Yvert5 email, Benoit de Courtivron5 email, Makram Ziade4 email, Yves Bertrand6 email, Christian Carrie7 email, Pascal Chastagner8 email, Cécile Bost-Bru9 email, Jean-Claude Léonard10 email, Marie Ouache11 email, Liliane Boccon-Gibod12 email, Pierre Mary13 email, Jacques de Blic14 email, Isabelle Pin9 email, Daniel Wendling15 email, Yann Revillon16 email, Véronique Houdoin14 email, Véronique Forin17 email, Hubert Ducou Lepointe18 email, Jane Languepin19 email, Jeanne Wagnon20 email, Ralph Epaud21 email, Brigitte Fauroux21 email and Jean Donadieu1 email

Service d'hématologie oncologie pédiatrique, Centre de référence des histiocytoses, AP-HP Hôpital Armand Trousseau, Paris, France

Service de génétique, Centre de référence des maladies osseuses, AP-HP Hôpital Necker, Paris, France

Service d'anatomie et cytologie pathologique, AP-HP Hôpital Necker, Paris, France

Service de chirurgie plastique pédiatrique, Hôpital Lapeyronie, Montpellier, France

Service d'orthopédie, Hôpital Clocheville, CHU de Tours, France

Institut d'hématologie et d'oncologie Pédiatrique, Lyon, France

Département de radiothérapie, Centre Léon Bérard, Lyon, France

Service de Médecine Infantile, Hôpitaux de Brabois, Vandoeuvre les Nancy, France

Pédiatrie, Pôle Couple enfant, CHU de Grenoble, France

10  Institut Calot, Berck sur Mer, France

11  Service d'hématologie, AP-HP Hôpital Robert Debré, Paris, France

12  Service d'anatomie et cytologie pathologique, AP-HP Hôpital Armand Trousseau, Paris, France

13  Service d'orthopédie, AP-HP Hôpital Armand Trousseau, Paris, France

14  Service de pneumologie, AP-HP Hôpital Necker, Paris, France

15  Service de rhumatologie, CHU de Besançon, France

16  Service de chirurgie viscérale, AP-HP Hôpital Necker, Paris, France

17  Service de rééducation, Centre de référence des maladies osseuses, AP-HP Hôpital Armand Trousseau, Paris, France

18  Service de radiologie, AP-HP Hôpital Armand Trousseau, Paris, France

19  Service de pédiatrie générale, CHU de Limoges, France

20  Service de pédiatrie générale, CH de Morlaix, France

21  Service de pneumologie, Centre de référence des maladies pulmonaires rares, AP-HP Hôpital Armand Trousseau, Paris, France

author email corresponding author email

Orphanet Journal of Rare Diseases 2010, 5:3doi:10.1186/1750-1172-5-3

Published: 3 February 2010

Abstract

Objective

To document the epidemiological, clinical, histological and radiological characteristics of aggressive vascular abnormalities of bone in children.

Study design

Correspondents of the French Society of Childhood Malignancies were asked to notify all cases of aggressive vascular abnormalities of bone diagnosed between January 1988 and September 2009.

Results

21 cases were identified; 62% of the patients were boys. No familial cases were observed, and the disease appeared to be sporadic. Mean age at diagnosis was 8.0 years [0.8-16.9 years]. Median follow-up was 3 years [0.3-17 years]. The main presenting signs were bone fracture (n = 4) and respiratory distress (n = 7), but more indolent onset was observed in 8 cases. Lung involvement, with lymphangiectasies and pleural effusion, was the most frequent form of extraosseous involvement (10/21). Bisphosphonates, alpha interferon and radiotherapy were used as potentially curative treatments. High-dose radiotherapy appeared to be effective on pleural effusion but caused major late sequelae, whereas antiangiogenic drugs like alpha interferon and zoledrenate have had a limited impact on the course of pulmonary complications. The impact of bisphosphonates and alpha interferon on bone lesions was also difficult to assess, owing to insufficient follow-up in most cases, but it was occasionally positive. Six deaths were observed and the overall 10-year mortality rate was about 30%. The prognosis depended mainly on pulmonary and spinal complications.

Conclusion

Aggressive vascular abnormalities of bone are extremely rare in childhood but are lifethreatening. The impact of anti-angiogenic drugs on pulmonary complications seems to be limited, but they may improve bone lesions.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.